Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
6.26
-0.14 (-2.19%)
At close: Jan 17, 2025, 4:00 PM
6.60
+0.34 (5.43%)
Pre-market: Jan 21, 2025, 7:55 AM EST
Pulmonx Market Cap
Pulmonx has a market cap or net worth of $247.19 million as of January 21, 2025. Its market cap has decreased by -46.27% in one year.
Market Cap
247.19M
Enterprise Value
195.22M
1-Year Change
-46.27%
Ranking
Category
Stock Price
$6.26
Market Cap Chart
Since the IPO on October 1, 2020, Pulmonx's market cap has decreased from $1.33B to $247.19M, a decrease of -81.46%. That is a compound annual growth rate of -32.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 247.19M | -7.81% |
| Dec 31, 2024 | 268.12M | -45.11% |
| Dec 29, 2023 | 488.43M | 54.88% |
| Dec 30, 2022 | 315.36M | -73.31% |
| Dec 31, 2021 | 1.18B | -52.01% |
| Dec 31, 2020 | 2.46B | 84.60% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |